Kezar Life Sciences (KZR) Misses Q1 EPS by 227c

Kezar Life Sciences (NASDAQ: KZR) reported Q1 EPS of ($2.27).

For earnings history and earnings-related data on Kezar Life Sciences (KZR) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Tradeweb adds spread trading for European credit portfolios
• Western Midstream prices $700M in senior notes due 2036